The drug received accelerated approval for use in patients with metabolic dysfunction-associated steatohepatitis (MASH).

U.S. prices for obesity-treatment pills that Eli Lilly and Novo Nordisk aim to launch next year likely will be on par with their weight-loss injections, analysts and investors say, in a departure from the usual practice of charging more for new medicines despite pressure to cut prices.

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those with previous adverse reactions.

Many Mounjaro users are looking into alternative medications following news of a 170 percent price increase in the UK

Weight loss medications like Wegovy can be life-changing for people living with obesity or excess weight with related health conditions. Clinical trials show that people can lose up to 20 percent of their body weight over a 68-week period.

The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a form of liver disease. Shares climbed roughly 4.5% in Denmark (read more about [weight-loss drugs' s

His statement comes as CheqUp, one of the UK's largest providers of weight-loss treatments, reports sales of rival treatment Wegovy have jumped by more than 500 per cent in recent days as patients seek alternatives. Dr Donald Grant, GP and Senior Clinical ...

A sweeping analysis of global studies reveals that stopping weight loss drugs, including well-known treatments like Ozempic and Wegovy, often triggers a rapid return of lost pounds.